SCHEMBL8276178

SCHEMBL8276178

CCOc1cc(O[C@@H]2C[C@@H](C(N)=O)N(C(=O)OC(C)(C)C)C2)c2ccc(OC)c(C)c2n1

nearest known ligand 0.37

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 12/20 0.37
PDE4A P27815 3/20 0.37
PDE4C Q08493 3/20 0.37
PDE4D Q08499 3/20 0.37
UCHL1 P09936 1/20 0.35
PIK3CD O00329 3/20 0.35
PIK3CA P42336 2/20 0.35
PIK3CB P42338 2/20 0.35
PIK3CG P48736 2/20 0.35
P2RX3 P56373 1/20 0.34
MCL1 Q07820 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13201738 0.93 UCHL1 (0.37) PDE4BPDE4APDE4CPDE4DUCHL1
SCHEMBL13201737 0.92 P2RX3 (0.41) PDE4BPDE4APDE4CPDE4DUCHL1
SCHEMBL8275838 0.85 P2RX3 (0.36) UCHL1P2RX3MCL1
SCHEMBL8277884 0.84 PDE4B (0.39) PDE4BPDE4APDE4CPDE4DUCHL1
SCHEMBL14092831 0.84 P2RX3 (0.41) PDE4BPDE4APDE4CPDE4DUCHL1
SCHEMBL13201745 0.82 CTSB (0.48) PDE4BPDE4APDE4CPDE4DUCHL1
SCHEMBL13201741 0.82 CTSB (0.44) PDE4BPDE4APDE4CPDE4DP2RX3
SCHEMBL13219427 0.81 HTR3E (0.35) PDE4BPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL13219280 0.80 MMP2 (0.34) PDE4BPDE4APDE4CPDE4DPIK3CD
SCHEMBL3373457 0.80 CYP3A4 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7511157-B2 racemic mixtures, stereoisomers or optical isomers, useful as protease inhibitors; viricides BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-03-31 US disclosed
WO-2006007700-A1 HEPATITIS C INHIBITOR DIPEPTIDE ANALOGS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-01-26 WO disclosed